RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Charles River Laboratories International
C

Charles River Laboratories International portfolio

Charles River Laboratories International has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Latest deal: bit.bio · Nov 5, 2021.
About this page

Its most recent investment on record is bit.bio's Series B+ round in November 2021, alongside Metaplanet Holdings, ArchVentures SA, Resilience and 6 others. That company is in Health and bio.

What Charles River Laboratories International invests in

How Charles River Laboratories International invests

StageDealsCapital in rounds
Series B+ 1 100%undisclosed

Charles River Laboratories International portfolio companies

CompanyRound with Charles River Laboratories InternationalTotal raisedLatest raise
Bbit.bio
Health and bio
Series B+$75MNov 4, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Charles River Laboratories International. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Charles River Laboratories International, which is a subset of its real portfolio. API: /api/v1/investors/charles-river-laboratories-international (get a free API key). More: the most active VC firms and new venture capital funds.